Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes

J Med Virol. 2003 May;70(1):163-70. doi: 10.1002/jmv.10350.

Abstract

It was proposed recently that CEM CD4-positive T cells infected chronically by herpes simplex virus type 1 (HSV-1) and human immunodeficiency virus type 1 (HIV-1) (CEM(HSV/HIV)) may be used as a model for studying HIV/HSV interactions. To ascertain whether HSV-HIV coinfection of T lymphocytes has a role in promoting progression of lentiviral infection, T cells infected chronically by either HSV-1 (CEM(HSV)) or HIV-1 (CEM(HIV)) were challenged with a superinfecting dose of HIV-1 or HSV-1. The results show a positive influence on HIV growth when CEM(HIV) cells were superinfected with HSV-1 to an extent that was dependent on the multiplicity of superinfection used. In contrast, HIV superinfection of CEM(HSV) cells resulted in a delay of HIV-1 production and in a lack of HSV-mediated LTR transactivation. These effects were due to cell growth inhibition and apoptosis, resulting from persistent HSV-1 infection. Treatment of CEM(HSV) with acyclovir inhibited completely the HSV-1 cytopathic effects and allowed efficient HIV-1 replication. These data may be relevant in clarifying the role of HIV/HSV interaction in the pathogenesis of AIDS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir
  • Animals
  • Apoptosis
  • CD4-Positive T-Lymphocytes / virology*
  • Cell Line
  • Chlorocebus aethiops
  • HIV-1 / physiology*
  • Herpesvirus 1, Human / physiology*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Tumor Cells, Cultured
  • Vero Cells
  • Virus Replication*

Substances

  • Acyclovir